EXAS - Exact Sciences Corporation
NEXT EARNINGS:
May 13, 2026
EPS Est: $-0.19
|
Rev Est: $832.0M
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$103.18
DETAILS
HIGH:
$105.00
LOW:
$85.00
MEDIAN:
$105.00
CONSENSUS:
$103.18
DOWNSIDE:
0.26%
Market Cap:
19.75B
Volume:
2,072,097
Avg Volume:
3,633,373
52 Week Range:
38.81-103.67
Sector:
Healthcare
Industry:
Medical - Diagnostics & Research
Beta:
1.42
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
6,900
IPO Date:
2001-02-01
EPS (TTM):
-1.10
P/E Ratio:
-92.15
Revenue (TTM):
3.25B
Total Assets:
5.86B
Total Debt:
2.52B
Cash & Equiv:
956.00M
Rev Growth (5Y):
16.8%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
37.7%
ROCE:
-1.9%
Debt/Equity:
1.05
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-13 | $-0.21 | $-0.11 | -94.6% | $878.4M | $860.9M | +2.0% |
| 2025-11-03 | $0.24 | $-0.06 | +492.0% | $850.7M | $810.5M | +5.0% |
| 2025-08-06 | $0.22 | $-0.02 | +1200.0% | $811.1M | $810.1M | +0.1% |
| 2025-05-01 | $-0.21 | $-0.37 | +43.2% | $706.8M | $688.6M | +2.6% |
| 2025-02-19 | $-0.06 | $-0.29 | +79.3% | $713.4M | $697.9M | +2.2% |
| 2024-11-05 | $-0.21 | $-0.20 | -7.2% | $708.7M | $716.8M | -1.1% |
| 2024-07-31 | $-0.09 | $-0.37 | +75.7% | $699.3M | $690.0M | +1.3% |
| 2024-05-08 | $-0.50 | $-0.47 | -5.3% | $637.5M | $627.3M | +1.6% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.25B | 2.76B | 2.50B | 2.08B | 1.77B | 1.49B | 876.29M | 454.46M | 265.99M | 99.38M | 39.44M | 1.80M |
| Net Income | (207.95M) | (1.03B) | (204.15M) | (623.51M) | (595.62M) | (823.61M) | (213.09M) | (175.15M) | (114.40M) | (167.21M) | (157.80M) | (100.05M) |
| EPS | -1.10 | -5.59 | -1.13 | -3.54 | -3.48 | -5.45 | -1.62 | -1.43 | -0.99 | -1.63 | -1.71 | -1.25 |
| Total Assets | 5.86B | 5.93B | 6.47B | 6.23B | 6.68B | 4.93B | 3.51B | 1.52B | 598.56M | 377.04M | 364.30M | 311.62M |
| Total Debt | 2.52B | 2.75B | 2.55B | 2.45B | 2.38B | 2.33B | 955.03M | 689.25M | 4.45M | 5.49M | 6.02M | 3.89M |
| Cash & Equivalents | 956.00M | 600.89M | 605.38M | 242.49M | 315.47M | 1.49B | 177.25M | 160.43M | 77.49M | 48.92M | 41.13M | 58.13M |
| Operating Cash Flow | 491.44M | 210.54M | 156.12M | (223.56M) | (102.24M) | 136.48M | (111.66M) | (69.33M) | (71.72M) | (130.07M) | (134.02M) | (80.91M) |
| Free Cash Flow | 356.78M | 74.55M | 31.93M | (438.02M) | (238.00M) | 72.13M | (284.31M) | (220.00M) | (140.96M) | (144.92M) | (156.00M) | (93.45M) |
| FCF per Share | 1.89 | 0.40 | 0.18 | -2.48 | -1.39 | 0.48 | -2.17 | -1.80 | -1.22 | -1.42 | -1.69 | -1.16 |
| Book Value | 2.40B | 2.40B | 3.15B | 3.04B | 3.39B | 2.24B | 2.29B | 680.94M | 520.42M | 335.30M | 326.86M | 288.98M |
| Cash & ST Investments | 964.71M | 1.04B | 777.64M | 632.06M | 1.03B | 1.84B | 323.65M | 1.12B | 424.71M | 311.10M | 306.88M | 282.76M |
| ROC Equity | -0.09 | -0.43 | -0.06 | -0.20 | -0.18 | -0.37 | -0.09 | -0.26 | -0.22 | -0.50 | -0.48 | -0.35 |